Try our Advanced Search for more refined results
Cannabis
Cannabis Law360 provides breaking news and analysis of emerging and evolving legal issues surrounding cannabis. Coverage ranges from regulatory and policy concerns facing the industry to the business of lawyers who counsel cannabis companies. Among the practice areas covered are intellectual property, mergers & acquisitions and employment.
Sign up for a 7-day FREE trial today!
Latest News in Cannabis
-
April 24, 2024
DEA's Upcoming Decision On Cannabis Likely To Be Litigated
The potential loosening of federal restrictions on marijuana is likely to be litigated for years, and the pro-legalization camp would do well to pool resources to build the most persuasive evidentiary record it can, a leading cannabis advocate said Wednesday.
-
April 24, 2024
FDA Can Keep Most Docs Hidden From Juul's FOIA Request
A District of Columbia federal judge has largely sided with the U.S. Food and Drug Administration in a suit by Juul Labs Inc. seeking documents related to the FDA's decision to ban its products, saying the bulk of the files fall under a privilege that protects predecision deliberations.
-
April 24, 2024
FDA Seeks Max Fines Against Shops Selling Elf Bar Vapes
The U.S. Food and Drug Administration has issued another round of complaints and civil penalties to 22 brick-and-mortar and online sellers of illicit e-cigarettes, including the highly popular Elf Bar brand, according to an agency announcement that noted more than 100 retailers have been hit since September.
-
April 23, 2024
Residents Say NJ Township, Grower Rushed Land Use Permits
Residents of a New Jersey neighborhood are hopping mad about plans to put a cannabis growing facility a stone's throw from their residential street, telling a state court that the local township didn't properly assess the site plan for the project before approving it.
-
April 23, 2024
Do Not Remand FDA Cigar Rule Without Vacatur, DC Circ. Told
The New Civil Liberties Alliance is urging the D.C. Circuit not to remand a U.S. Food and Drug Administration rule regulating premium cigars without first vacating the regulation, saying federal agencies cannot enforce rules that have been declared unlawful.
Areas of Coverage
- AGENCIES
- U.S. Food & Drug Administration
- Federal Trade Commission
- Drug Enforcement Agency
- U.S. Department of the Treasury
- California Bureau of Cannabis Control
- Department of Health & Human Services
- Financial Crimes Enforcement Network
- U.S. Securities and Exchange Commission
- U.S. Commodity Futures Trading Commission
- U.S. Department of Justice
- State and international regulators
- POLICY & REGULATION
- SAFE Banking Act
- STATES Act
- Marijuana Opportunity Reinvestment and Expungement, or MORE, Act
- Section 280E of the Internal Revenue Code
- Rohrabacher–Farr amendment
- Bank Secrecy Act
- Federal and state legislation
- ENFORCEMENT
- FDA and FTC actions over cannabis’s purported health claims
- IRS actions against cannabis companies
- Antitrust investigations
- Financial regulatory actions
- Federal criminal matters
- State enforcement actions
- LITIGATION
- Civil RICO actions brought against cannabis concerns
- Employment disputes
- Securities class actions
- Intellectual property matters
- Consumer class actions
- Bankruptcy
- Tax disputes
- Challenges to federal or state regulations
- TRANSACTIONS
- M&A activity involving cannabis companies
- Commercial real estate transactions
- PROFILES
- Personnel moves
- Profiles of law firm cannabis practices
- Federal and state policymakers and lawmakers
- General counsel interviews
READERSHIP
- Cannabis lawyers at large to medium-sized law firms and boutiques
- In-house counsel, compliance officers and executives at cannabis companies
- Counsel and executives at venture capital and investment firms
- Policymakers at federal and state agencies
- Federal and state lawmakers
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.